You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 1, January 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Procedures
 •Phototherapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Trial of Short Incubation, Broad-Area Photodynamic Therapy for Facial Actinic Keratoses and Diffuse Photodamage

Dany Touma, MD; Mina Yaar, MD; Sara Whitehead, MD; Nellie Konnikov, MD; Barbara A. Gilchrest, MD

Arch Dermatol. 2004;140:33-40.

Background  There is no completely satisfactory treatment for multiple actinic keratoses (AKs).

Objective  To evaluate the efficacy of short incubation, broad-area application of {delta}-aminolevulinic acid followed by exposure to activating light–photodynamic therapy ({delta}-ALA/PDT) for treatment of AKs and background photodamage. The benefit of pretreatment with 40% urea cream to enhance penetration and the use of topical 3% lidocaine hydrochloride to decrease discomfort were also evaluated.

Methods  Eighteen patients with at least 4 nonhypertrophic facial AKs and mild to moderate diffuse facial photodamage were enrolled in the study. For 7 days, 40% urea cream or vehicle was applied to half of the treatment area, and then {delta}-ALA was applied to the entire area for 1, 2, or 3 hours. Lidocaine hydrochloride (3%) or vehicle cream was also applied to the entire area 45 minutes before exposure to 10 J/cm2 of blue light. Pain,phototoxic reactions, AK counts, and photodamage improvement were evaluated 1 day, 1 week, and 1 month after treatment in all patients and after 5 months in 10 patients.

Results  All patients experienced mild to moderate discomfort during treatment and moderate phototoxic effects for 1 week. At 1 and 5 months there was significant reduction in AKs in all groups and significant improvement of several photodamage parameters. Different {delta}-ALA application times and pretreament with urea cream or lidocaine had no significant effect on the results.

Conclusions  This {delta}-ALA/PDT protocol is safe and effective for AK treatment as well as for improving photodamage. Further studies with a larger cohort, longer follow-up, and histologic confirmation of the clinical data would be of value.


From the Department of Dermatology, Boston University School of Medicine, Boston, Mass. The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Photodynamic Therapy for Nonmelanoma Skin Cancer—and More?
Colin A. Morton
Arch Dermatol. 2004;140(1):116-120.
EXTRACT | FULL TEXT  

Photodynamic Therapy Using Topical Methyl Aminolevulinate vs Surgery for Nodular Basal Cell Carcinoma: Results of a Multicenter Randomized Prospective Trial
Lesley E. Rhodes, Menno de Rie, Ylva Enström, Richard Groves, Tore Morken, Victoria Goulden, Gavin A. E. Wong, Jean-Jacques Grob, Sandeep Varma, and Peter Wolf
Arch Dermatol. 2004;140(1):17-23.
ABSTRACT | FULL TEXT  

Photodynamic Therapy of Multiple Nonmelanoma Skin Cancers With Verteporfin and Red Light–Emitting Diodes: Two-Year Results Evaluating Tumor Response and Cosmetic Outcomes
Harvey Lui, Lori Hobbs, Whitney D. Tope, Peter K. Lee, Craig Elmets, Nathalie Provost, Agnes Chan, Herma Neyndorff, Xiang Yao Su, Hem Jain, Iltefat Hamzavi, David McLean, and Robert Bissonnette
Arch Dermatol. 2004;140(1):26-32.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Aminolevulinic Acid Topical Solution and Visible Blue Light in the Treatment of Multiple Actinic Keratoses of the Face and Scalp: Investigator-Blinded, Phase 3, Multicenter Trials
Daniel J. Piacquadio, Diana M. Chen, Harold F. Farber, Joseph F. Fowler, Jr, Scott D. Glazer, J. John Goodman, Luciann L. Hruza, Edward W. B. Jeffes, Mark R. Ling, Tania J. Phillips, Tena M. Rallis, Richard K. Scher, Charles R. Taylor, and Gerald David Weinstein
Arch Dermatol. 2004;140(1):41-46.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular Effects of Photodynamic Therapy for Photoaging
Orringer et al.
Arch Dermatol 2008;144:1296-1302.
ABSTRACT | FULL TEXT  

Treatment of Diffuse Basal Cell Carcinomas and Basaloid Follicular Hamartomas in Nevoid Basal Cell Carcinoma Syndrome by Wide-Area 5-Aminolevulinic Acid Photodynamic Therapy
Oseroff et al.
Arch Dermatol 2005;141:60-67.
ABSTRACT | FULL TEXT  

Rejuvenating the Aging Face
Hruza
Arch Facial Plast Surg 2004;6:366-369.
FULL TEXT  

Rejuvenating the Aging Face
Hruza
Arch Dermatol 2004;140:1383-1386.
FULL TEXT  

Photodynamic Therapy for Nonmelanoma Skin Cancer--and More?
Morton
Arch Dermatol 2004;140:116-120.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.